CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+9.84%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$15.7B
AUM Growth
+$15.7B
(+6.5%)
Cap. Flow
-$63.5M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
22.96%
Holding
929
New
41
Increased
265
Reduced
360
Closed
129
Top Buys
| 1 |
Eli Lilly
LLY
|
$106M |
| 2 |
PayPal
PYPL
|
$58.2M |
| 3 |
Hologic
HOLX
|
$46.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.7M |
| 5 |
Intuitive Surgical
ISRG
|
$34.3M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$79.5M |
| 2 |
Merck
MRK
|
$77.4M |
| 3 |
Apple
AAPL
|
$62.7M |
| 4 |
Verizon
VZ
|
$37.8M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$36M |
Sector Composition
| 1 | Healthcare | 31.3% |
| 2 | Technology | 26.69% |
| 3 | Financials | 8.86% |
| 4 | Communication Services | 7.82% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
176
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $20.3M | 0.13% |
1,215,272
| – | – |
|
|
SPLK
177
DELISTED
Splunk Inc
SPLK
| $20.2M | 0.13% |
174,410
-5,730
| -3% | -$663K |
|
178
Edwards Lifesciences
EW
$47.8B
| $19.9M | 0.13% |
153,540
+38,591
| +34% | +$5M |
|
179
Ally Financial
ALLY
$12.6B
| $19.6M | 0.13% |
412,204
+31,633
| +8% | +$1.51M |
|
180
Illinois Tool Works
ITW
$77.1B
| $19.4M | 0.12% |
78,558
-35,143
| -31% | -$8.67M |
|
181
lululemon athletica
LULU
$24.2B
| $19.3M | 0.12% |
49,342
-3,351
| -6% | -$1.31M |
|
182
Curis
CRIS
$20.9M
| $19.3M | 0.12% |
4,054,920
+1,032,614
| +34% | +$4.92M |
|
183
Bristol-Myers Squibb
BMY
$96B
| $19.2M | 0.12% |
308,591
-72,359
| -19% | -$4.51M |
|
|
GBT
184
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $19M | 0.12% |
648,339
+314,298
| +94% | +$9.2M |
|
|
XLNX
185
DELISTED
Xilinx Inc
XLNX
| $18.7M | 0.12% |
88,213
-36,159
| -29% | -$7.67M |
|
186
Trex
TREX
$6.61B
| $18.7M | 0.12% |
138,439
-60,293
| -30% | -$8.14M |
|
187
Exact Sciences
EXAS
$8.98B
| $18.4M | 0.12% |
236,833
+5,974
| +3% | +$465K |
|
|
MGLN
188
DELISTED
Magellan Health Services, Inc.
MGLN
| $18.4M | 0.12% |
193,817
| – | – |
|
|
KDNY
189
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $18M | 0.12% |
1,104,902
+202,365
| +22% | +$3.3M |
|
190
Equity Residential
EQR
$25.3B
| $17.9M | 0.11% |
198,303
+63,066
| +47% | +$5.71M |
|
|
FRTA
191
DELISTED
Forterra, Inc
FRTA
| $17.5M | 0.11% |
734,897
| – | – |
|
192
Labcorp
LH
$23.1B
| $17.4M | 0.11% |
55,504
+3,809
| +7% | +$1.2M |
|
|
Y
193
DELISTED
Alleghany Corporation
Y
| $17.3M | 0.11% |
25,912
-6,786
| -21% | -$4.53M |
|
194
Iovance Biotherapeutics
IOVA
$807M
| $17.1M | 0.11% |
896,364
+47,712
| +6% | +$911K |
|
195
Scotiabank
BNS
$77.6B
| $16.9M | 0.11% |
239,020
-267,196
| -53% | -$18.9M |
|
196
Marsh & McLennan
MMC
$101B
| $16.9M | 0.11% |
97,408
+61,251
| +169% | +$10.6M |
|
197
Xenon Pharmaceuticals
XENE
$2.98B
| $16.6M | 0.11% |
530,511
-185,211
| -26% | -$5.79M |
|
198
ResMed
RMD
$40.2B
| $16.5M | 0.11% |
63,232
+45,056
| +248% | +$11.7M |
|
|
INBX
199
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $16.4M | 0.1% |
+375,326
| New | +$16.4M |
|
200
Best Buy
BBY
$15.6B
| $16.4M | 0.1% |
160,985
-16,078
| -9% | -$1.63M |
|